
|Articles|December 1, 2021
Daily OTC Pearl: Tiger Balm
Author(s)Saro Arakelians, PharmD
Tiger Balm is frequently used for the relief of back pain, joint pain, stiffness, sprains, and arthritis pain.
Advertisement
OTC/Lifestyle Pearl of the Day: Tiger Balm
Indication: Tiger Balm is a topical OTC pain reliever that contains ingredients such as camphor, menthol, cajuput oil, and
Insight:
- Tiger Balm is often used for the relief of a variety of types of pain, including back pain,
joint pain , stiffness, sprains, andarthritis pain . - History: Tiger Balm has a long history. It is manufactured and distributed by Haw Par Healthcare in Singapore, boasting a "secret" herbal formula that dates back as far as the Chinese emperors. Today, more than 20 million jars of Tiger Balm are sold each year in over 70 countries.
- The active ingredients include:
- Camphor, which comes from the Cinnamomum camphora plant, induces warm and cold sensations in the skin and increases blood flow.
- Menthol, which is made from mint oils, may induce constriction of the muscles inside the blood vessels, which has been shown to reduce pain.
- Cajuput oil comes from cajuput trees and is used for pain relief from toothaches and headaches in some cultures.
- Cassia oil, which comes from the bark of the Cinnamomum cassia plant, may have an anti-inflammatory effect.
- Demetholized mint oil comes from a peppermint plant and has been used as a topical treatment for pain.
- Clove oil, which comes from a clove plant, is used for pain relief from toothaches.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
2
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
3
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
4
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
5









































































































































































































